Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ARG1 | P05089 | 2/20 | 0.39 |
| ▸ | ARG2 | P78540 | 1/20 | 0.39 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL16993455 | 0.97 | ARG1 (0.38) | ARG1ARG2FFAR3 | |
| SCHEMBL3934353 | 0.92 | ARG1 (0.34) | ARG1ARG2FFAR3CYP2C19 | |
| SCHEMBL18076610 | 0.86 | ARG1 (0.35) | ARG1ARG2FFAR3 | |
| SCHEMBL18076611 | 0.86 | ARG1 (0.35) | ARG1ARG2FFAR3 | |
| SCHEMBL2900265 | 0.86 | ARG1 (0.39) | ARG1ARG2 | |
| SCHEMBL1234317 | 0.83 | ARG1 (0.33) | ARG1ARG2FFAR3 | |
| SCHEMBL5494842 | 0.81 | ARG1 (0.33) | ARG1ARG2 | |
| SCHEMBL30557677 | 0.81 | ARG1 (0.36) | ARG1ARG2 | |
| SCHEMBL8371988 | 0.80 | FFAR3 (0.31) | ARG1ARG2FFAR3 | |
| SCHEMBL8993303 | 0.80 | FFAR3 (0.31) | ARG1ARG2FFAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109516942-A | A kind of 4- methylene pyrrole alkane derivative and its synthetic method | 中国药科大学 | 2019-03-26 | — | — | CN | claimed |
| WO-1997049725-A9 | MODIFIED FACTOR VIII | UNIV EMORY (US) | 2005-11-17 | — | — | WO | claimed |
| CN-109516942-A | A kind of 4- methylene pyrrole alkane derivative and its synthetic method | 中国药科大学 | 2019-03-26 | — | — | CN | disclosed |
| US-20120071669-A1 | PROCESS FOR PREPARATION OF ELETRIPTAN AND SALT THEREOF | USV Limited B.S.D. Mar (IN) | 2012-03-22 | — | — | US | disclosed |
| EP-1561757-A1 | Modified factor VIII | EMORY UNIVERSITY (US) | 2005-08-10 | — | — | EP | disclosed |
| US-5942537-A | ADMINISTERING A L-TRANS PYRROLIDINE DERIVATIVE TO INHIBIT THE TRANSPORT OF L-GLUTAMATE OR L-ASPARTATE OR AN EXCITATORY AMINO ACID NEUROTRANSMITTER AWAY FROM A SYNAPSE COMPRISING CONTACTING SYNAPSE WITH PYRROLIDINE DERIVATIVE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-08-24 | — | — | US | disclosed |
| EP-0497895-A1 | METHOD OF INHIBITING THE TRANSPORT OF L-GLUTAMATE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1992-08-12 | — | — | EP | disclosed |
| WO-1991006536-A1 | METHOD OF INHIBITING THE TRANSPORT OF L-GLUTAMATE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1991-05-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071669-A1 | PROCESS FOR PREPARATION OF ELETRIPTAN AND SALT THEREOF | HTR3C, SLC6A4, HTR3A | ARG1 3262/4885ARG2 3716/4885FFAR3 1348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.